Edap Tms (NASDAQ:EDAP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note published on Saturday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Edap Tms Stock Performance

Shares of Edap Tms stock opened at $2.50 on Friday. The firm has a market cap of $92.75 million, a price-to-earnings ratio of -3.85 and a beta of 0.36. The business has a 50-day moving average price of $2.28 and a 200-day moving average price of $2.88. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. Edap Tms has a twelve month low of $2.00 and a twelve month high of $8.50.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Redhawk Wealth Advisors Inc. purchased a new position in Edap Tms in the third quarter worth about $36,000. Illumine Investment Management LLC purchased a new position in Edap Tms in the fourth quarter worth about $50,000. BNP Paribas Financial Markets grew its position in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares in the last quarter. Orion Capital Management LLC grew its position in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares in the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new position in Edap Tms in the third quarter worth about $395,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.